The whole world is waiting for "COVID-19 vaccine" believe it will not be used over the next year ..

Except for economic and political matters Sure today Another issue that people all over the world are waiting for Probably a vaccine against COVID-19, which many countries are rushing to study and improve in hopes of Produced out to be used by people of the world who are facing a new disease from cattle that can carry the virus.

Reuters currently reported that following a consultation between Russian Ambassador Victor Voironelli to Mexico and Mexico's Foreign Minister Marcelo Ebrad. Marcelo tweeted his satisfaction in testing with many people to have a vaccine in Mexico as soon as possible. With confidence that the management of a vaccine against cattle vaccine against VID-19 Of Russia, as part of Latin America's considerable endeavors. For finding quality drugs to control the outbreak of vid-19 cattle. In addition to working with Russia to develop a vaccine against VID-19, Mexico has also partnered with British pharmaceutical company AstraZeneca. And the University of Oxford Improved vaccine to feed Latin America. Moreover, Mexico It is still in the process of preparing to experiment with many people. For vaccines modified by the U.S. Johnson & Johnson Company And two other Chinese companies

China, news reports from foreign news agencies, said the vaccine against Cows was VID-19. It was developed by China National Pharmaceutical Group (Sinopharm), a Chinese pharmaceutical manufacturer. Which is under trial with most people in the United Arab Emirates To look at the quality of maintenance And it's safety in people There have been many advances as follows: China National Biotec Group (CNBG) with Sinofarm. As part of the CNBG, it has improved the vaccine against VID-19 with two plants in Wuhan. And then Beijing With a combined production capacity of more than 200 million doses per year, when produced, it would be sold for around 1,000 yuan or more than 4,500 baht for two injections.

The news mentioned in the past reflects the opinion that The superpowers are now racing to improve the vaccine against the VID-19. To compete for influence And the honor of being a great power In the time of the underdeveloped country I just want to make sure that There will be a fair distribution of vaccines.

The New York Times reveals information about the development of a cow vaccine. More than 140 are currently being developed by research teams from around the world. In which the conventional stages of vaccine development It has to be studied, learned, as well as tested before it is allowed to be exploited to the sick. But with the disease, the VID-19 is an urgent case that scientists all over the world need to speed up the process of improvement and testing. To be able to produce the quality and safety vaccine as targeted in the next year.

Development of a vaccine for cattle Vid-19 First started in January By decoding the genome data of the 2019 new bovine rona virus (SARS-CoV-2) that causes the disease of cattle VID-19. Before going to the test in humans Or tested in a non-hazardous hospital for the first time in March.

But the results of an unstable test sometimes cause a study to fail or show an unclear results. And only a handful of groups have reached their goals. Even so, the vaccine can stimulate the immune system and generate immune response to fight the virus.

The current attraction is the Russian vaccine against VID-19, Sputnik V, named after Russia's first satellite in the world. It is estimated that It is likely the first vaccine against VID-19 to be produced on the market. And it will be released at the end of this month Russia produced the first vaccine. Although not yet tried phase 3, which is the last phase To test the safety And the ability of the vaccine However, the Ministry of Health has approved the production.

There are currently a number of private research teams in the United States, China, South Korea, England, France and Germany. That improved the vaccine in this way By a team of researchers with the most advanced Phase II human trials are underway, such as US company Moderna, a combined research team from Germany's BioNTech, US Pfizer and China's Fosun Pharma and Britain's Imperial College London.

By adopting a well-established and highly anticipated approach, Viral Vector Vaccines mean Viral Vector Vaccines are vaccines enhancing the use of a weakened and non-pathogenic virus. Let's cut and put on all sins of the cow rona virus 2019 to stimulate the body to build immunity. There are now three teams of researchers who are bringing vaccines that are improved with this approach. For example, a team of researchers at British and Swedish major drugmaker AstraZeneca. In collaboration with the University of Oxford The research team is even more prosperous with Phase III human trials and is funded by the Warp Speed ​​plan, which is expected to potentially deliver an urgent vaccine from October.

A team of researchers from the Chinese company Can-Sino Biologics in collaboration with the Institute of Biology. Of the Chinese Academy of Military Medical Sciences Which has developed in a human experiment phase 2, and there is information that the effect of improvement Can make the vaccine progressively stimulate the immune response It was until the Chinese military approved the use of the vaccine in the military on June 25 earlier, and a team of researchers at the Gamaleya Research Institute, part of the Russian Ministry of Health. The first phase 1 human vaccine trial began in June.

Another approach means that enhanced Whole-Virus Vaccines using weakened viruses work to stimulate the immune system's response. Developing a vaccine with this approach, now there are only three teams of researchers from China. Such as the สมัครเว็บts911 Chinese government Sinopharm, Sinovac Biotech and the Chinese Academy of Medical Sciences. In this study, Sinopharm has produced quite good results and is currently in the third phase of human trials.

The most exciting thing is Creating a vaccine that would have to be applied to 7 billion people on the planet poses a huge challenge to keep ahead.